Skip to main content
. Author manuscript; available in PMC: 2012 Jun 21.
Published in final edited form as: J Neurosurg. 2010 Oct;113(4):802–809. doi: 10.3171/2009.10.JNS09562

TABLE 1.

Physiological parameters in animals from the permanent (24-hour) ischemia experiment (Experiment 1)*

Dosage & Timing of Measurements MABP (mm Hg) HR (beats/min) pH PCO2 (mm Hg) PO2 (mm Hg)
 vehicle
  before 3-VO 122.9 ± 4.2 353.4 ± 8.8 7.453 ± 0.020 29.1 ± 2.8 168.0 ± 12.3
  during 3-VO & infusion 122.8 ± 2.8 377.2 ± 11.4 7.446 ± 0.022 29.2 ± 2.5 175.8 ± 10.6
  after infusion 125.8 ± 2.2 385.5 ± 6.5 7.427 ± 0.026 31.3 ± 2.2 176.1 ± 9.2

 0.023 mg/kg TSC
  before 3-VO 121.1 ± 3.7 376.6 ± 7.2 7.470 ± 0.019 28.2 ± 1.8 178.6 ± 8.1
  during 3-VO & infusion 119.6 ± 4.0 394.7 ± 10.8 7.474 ± 0.011 31.9 ± 0.7 178.5 ± 7.9
  after infusion 124.0 ± 5.1 392.2 ± 10.2 7.458 ± 0.018 28.5 ± 2.0 179.3 ± 9.4

 0.046 mg/kg TSC
  before 3-VO 121.6 ± 3.2 369.1 ± 5.6 7.455 ± 0.016 32.0 ± 2.6 190.2 ± 7.1
  during 3-VO & infusion 123.6 ± 3.4 386.3 ± 12.5 7.457 ± 0.017 31.2 ± 2.3 176.8 ± 6.3
  after infusion 119.5 ± 1.7 377.3 ± 14.4 7.460 ± 0.017 32.1 ± 2.8 168.6 ± 7.5

 0.092 mg/kg TSC
  before 3-VO 125.0 ± 6.8 364.6 ± 8.0 7.480 ± 0.015 31.5 ± 2.6 192.5 ± 7.0
  during 3-VO & infusion 124.4 ± 4.1 386.4 ± 13.9 7.451 ± 0.016 30.6 ± 1.5 183.3 ± 6.8
  after infusion 122.8 ± 3.3 376.4 ± 15.8 7.426 ± 0.007 33.8 ± 1.6 168.2 ± 8.8

 0.230 mg/kg TSC
  before 3-VO 116.3 ± 5.4 378.3 ± 9.8 7.474 ± 0.013 30.3 ± 1.5 185.7 ± 9.8
  during 3-VO & infusion 121.8 ± 4.3 394.7 ± 4.0 7.461 ± 0.017 30.2 ± 1.5 190.6 ± 9.8
  after infusion 131.3 ± 6.3 397.5 ± 12.1 7.453 ± 0.016 30.4 ± 2.3 187.6 ± 6.4

 0.458 mg/kg TSC
  before 3-VO 117.5 ± 3.4 339.7 ± 17.6 7.457 ± 0.014 30.5 ± 2.1 167.5 ± 12.0
  during 3-VO & infusion 128.5 ± 6.7 357.3 ± 18.7 7.433 ± 0.020 29.4 ± 2.6 171.9 ± 11.4
  after infusion 125.2 ± 6.2 355.2 ± 5.9 7.436 ± 0.006 29.7 ± 1.9 174.4 ± 11.2

 0.916 mg/kg TSC
  before 3VO 113.7 ± 4.4 347.3 ± 6.7 7.432 ± 0.012 31.4 ± 2.3 177.1 ± 7.7
  during 3-VO & infusion 115.9 ± 4.0 370.1 ± 10.5 7.447 ± 0.015 32.2 ± 1.7 182.2 ± 6.8
  after infusion 110.7 ± 2.3 364.9 ± 7.1 7.444 ± 0.012 31.6 ± 1.5 184.8 ± 4.9

 2.290 mg/kg TSC
  before 3-VO 118.8 ± 6.7 347.2 ± 7.9 7.451 ± 0.021 31.7 ± 1.8 177.4 ± 6.3
  during 3-VO & infusion 119.6 ± 5.3 359.8 ± 8.6 7.435 ± 0.007 32.0 ± 2.2 178.2 ± 4.5
  after infusion 116.8 ± 4.7 356.4 ± 9.1 7.439 ± 0.005 31.6 ± 1.6 182.8 ± 4.6

 4.580 mg/kg TSC
  before 3-VO 110.7 ± 2.7 357.0 ± 12.3 7.452 ± 0.017 27.6 ± 2.6 178.8 ± 8.2
  during 3-VO & infusion 113.1 ± 2.5 374.3 ± 11.1 7.456 ± 0.015 30.6 ± 2.0 175.4 ± 6.7
  after infusion 111.1 ± 2.3 362.4 ± 12.0 7.443 ± 0.013 31.6 ± 2.5 179.9 ± 4.8
*

Values shown are means ± SEs. No significant intergroup differences were observed for MABP, heart rate, blood pH, blood PCO2, or blood PO2.

Abbreviations: HR = heart rate; pH = blood pH; PCO2 = blood PCO2; PO2 = blood PO2.